Singapore General Hospital (SGH) patients are expected to benefit from healthcare innovations, such as customized medical devices and implants, under a collaboration with Nanyang Technological University, Singapore (NTU Singapore) to set up a Joint Research & Development Laboratory in additive manufacturing (AM), also known as 3D printing.
Ubiquigent enters agreement with Astellas subsidiary, Nanna Therapeutics
Agreement leverages Ubiquigent’s DUB-focused drug discovery platform to support the development of novel therapeutic candidates for multiple disease targets selected by Nanna Therapeutics.